Clinical Report: Evaluating ChatGPT Responses Against 2025 ESC/EACTS Guidelines

Overview

This study assesses the consistency of ChatGPT responses in relation to the 2025 ESC/EACTS guidelines for valvular heart disease management. The findings indicate variability in AI performance, highlighting the need for critical evaluation of AI-generated clinical information.

Background

Valvular heart disease (VHD) significantly impacts patient outcomes, often leading to heart failure and increased mortality. The complexity of VHD management necessitates reliable access to current clinical guidelines, such as those from the ESC and EACTS. As AI tools like ChatGPT gain traction in clinical settings, understanding their reliability in providing guideline-based recommendations becomes crucial for effective patient care.

Data Highlights

No numerical data was provided in the article.

Key Findings

• ChatGPT's responses were evaluated against the 2025 ESC/EACTS guidelines for VHD management.
• The study revealed variability in the consistency of ChatGPT's performance over repeated tests.
• AI-generated responses may sometimes contain misleading or incorrect information.
• There is a need for healthcare professionals to critically assess AI outputs before clinical application.
• Future research should explore AI performance across diverse populations to ensure equitable healthcare delivery.

Clinical Implications

Clinicians should exercise caution when utilizing AI tools like ChatGPT for decision support in VHD management. Continuous evaluation and validation of AI responses against established guidelines are essential to ensure patient safety and effective treatment strategies.

Conclusion

The study underscores the potential of AI in clinical decision support while highlighting the importance of critical evaluation of AI-generated information. Ongoing research is necessary to enhance the reliability of AI applications in cardiology.

Related Resources & Content

1. European Heart Journal, 2025 -- 2025 ESC/EACTS Guidelines for the management of valvular heart disease
2. Infection, 2024 -- Evaluating the Theoretical Knowledge and Treatment Recommendations of ChatGPT in Bacterial Infections
3. The Journal of Clinical Endocrinology & Metabolism, 2025 -- Evaluating Responses to Thyroid-Related Inquiries
4. Frontiers in Cardiovascular Medicine, 2026 -- Retrospective comparison of ChatGPT-4 treatment recommendations
5. Obesity Surgery, 2023 -- Evaluating the Precision of ChatGPT's Responses to Inquiries About Bariatric Surgery
6. 2025 ESC/EACTS Guidelines for the management of valvular heart disease | European Heart Journal | Oxford Academic
7. Evolut Low Risk: TAVR Noninferior to SAVR at 5-Year Follow-Up - American College of Cardiology
8. Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: A Meta-analysis and Trial Sequential Analysis of Randomized Trials - PMC